Question 1 · Medium
Pits on the palms, jaw cysts removed twice, calcification of the falx on skull X-ray and more than twenty basal cell carcinomas by the age of 30 are found in a man whose father had the same. Surgery is no longer practical for all his tumours. Which drug acts on the pathway his mutation disturbs?
- AVismodegib
- BImatinib
- CVemurafenib
- DSirolimus
Show answerHide answer
Answer: A · Vismodegib
Multiple early BCCs with palmar pits, odontogenic keratocysts and falx calcification are Gorlin (naevoid basal cell carcinoma) syndrome, from germline loss of PTCH1. Normally PTCH1 holds back Smoothened; without it the hedgehog pathway is constantly active. Vismodegib and sonidegib inhibit Smoothened and shrink BCCs in this syndrome and in advanced or metastatic BCC, though muscle cramps, taste loss and hair loss limit their use. Key point: Gorlin syndrome is PTCH1 loss; Smoothened inhibitors (vismodegib) treat its multiple BCCs.
- B: Imatinib targets BCR-ABL and KIT.
- C: Vemurafenib targets BRAF V600 in melanoma.
- D: Sirolimus inhibits mTOR and is used in tuberous sclerosis.